Seller record · remevihealth.com

REMEVi

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: No certificate or lot report is published. The pharmacy answers tell buyers to ask the dispensing pharmacy for testing information on their own lot.

At a glance

REMEViremevihealth.com

7/8criteria passed
Price
Semaglutide from $159, tirzepatide from $225 per 4 weeks
Sells
compounded semaglutide, compounded tirzepatide, and 3 more
FDA letters
None on file
Visit REMEViSee all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A bilingual English and Spanish telehealth service selling compounded semaglutide and tirzepatide injections, compounded oral semaglutide, sermorelin and NAD+. It prints one price per plan at every dose and names four filling pharmacies with street addresses.

Operating entity REMEVi LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSremevihealth.com/pricing, remevihealth.com/medical-team
S2Prescription gatingPASSstart.remevihealth.com/start
S3Pharmacy identificationPASSremevihealth.com/terms, remevihealth.com/pharmacies
S4Compounding disclosurePASSremevihealth.com/pricing, remevihealth.com/pharmacies
S5Analytical documentationFAILremevihealth.com/pharmacies
S6Business addressPASSremevihealth.com/contact, remevihealth.com/terms
S7Price disclosurePASSremevihealth.com/pricing, remevihealth.com/nad-injections, remevihealth.com/sermorelin
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSClinicians in the OpenLoop network who are licensed in the buyer's state review each questionnaire and decide whether a prescription is appropriate.Source: remevihealth.com/pricing, remevihealth.com/medical-team.
S2PASSEvery start button opens a questionnaire whose first screen asks what the buyer hopes to get back, with checkout listed as a later step and no card needed to begin.Source: start.remevihealth.com/start.
S3PASSFour pharmacies are named with street addresses in the terms and on a pharmacy page: RedRock Pharmacy, Health Warehouse, Precision Medicine and Triad Rx.Source: remevihealth.com/terms, remevihealth.com/pharmacies.
S4PASSCompounded medications are not FDA-approved, printed beside the plan prices and on each product page, and the pharmacy answers add that compounded preparations are not approved generics.Source: remevihealth.com/pricing, remevihealth.com/pharmacies.
S5FAILNo certificate or lot report is published. The pharmacy answers tell buyers to ask the dispensing pharmacy for testing information on their own lot.Source: remevihealth.com/pharmacies.
S6PASSREMEVi LLC at 1635 Village Center Circle, Suite 250, Las Vegas, NV 89134, printed on the contact page, in the terms, the privacy policy and the refund policy.Source: remevihealth.com/contact, remevihealth.com/terms.
S7PASSSemaglutide at $199 per 4 weeks month to month, $169 on a 12-week plan and $159 on a 24-week plan prepaid at $954; tirzepatide at $269, $233 and $225; oral semaglutide at $249, $229 and $215. NAD+ is $229 per 4 weeks, and the sermorelin page prints both $229 and $227 per 4 weeks.Source: remevihealth.com/pricing, remevihealth.com/nad-injections, remevihealth.com/sermorelin.
S8PASSNo FDA warning letter names REMEVi or the operating entity REMEVi LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, compounded oral semaglutide, sermorelin, NAD+ injection, nasal spray and oral liquid.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+

Unpaid link. REMEVi does not pay the site, and nothing is earned when it is used. Funding.

Visit REMEVi

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.